Previous Article | Next Article 
Journal of Clinical Microbiology, November 2002, p. 4295-4297, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.4295-4297.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Direct Detection and Identification of African Trypanosomes by Fluorescence In Situ Hybridization with Peptide Nucleic Acid Probes
M. Radwanska,1* S. Magez,2 H. Perry-O'Keefe,3 H. Stender,3 J. Coull,3 J. M. Sternberg,4 P. Büscher,1 and J. J. Hyldig-Nielsen3
Department of Parasitology, Institute of Tropical Medicine, Antwerp,1
Laboratory of Cellular Immunology, Flanders Interuniversity Institute for Biotechnology, Free University of Brussels VUB, Brussels, Belgium,2
Applied Biosystems, Bedford, Massachusetts,3
University of Aberdeen, Aberdeen, Scotland4
Received 19 April 2002/
Returned for modification 18 June 2002/
Accepted 24 July 2002

ABSTRACT
We have developed a rapid and easy to perform fluorescence in
situ hybridization test that allows specific identification
of trypanosomes from the subgenus
Trypanozoon, using peptide
nucleic acid probes. Probes were designed to target subgenus-specific
sequences on the multiple-copy 18S rRNA, greatly facilitating
the detection of a single trypanosome.

TEXT
Trypanosomes belonging to the subgenus
Trypanozoon are protozoan
extracellular parasites that undergo continuous antigenic variation
(
14). Tsetse-transmitted
Trypanosoma brucei gambiense and
T. brucei rhodesiense cause human African trypanosomiasis (sleeping
sickness) and occur in West-Central and East Africa, respectively.
Animal infections with
T. brucei brucei,
Trypanosoma congolense,
and
Trypanosoma vivax appear through the whole African tsetse
belt, while non-tsetse-transmitted
Trypanosoma equiperdum and
Trypanosoma evansi are found worldwide (
5,
7,
8). Diagnosis
of human and animal infections is usually based on recognition
of clinical manifestations and the detection of parasites by
microscopy (
21), combined, in the case of
T. brucei gambiense infections, with a card agglutination test for trypanosomiasis
(
13). Here, we present a newly developed diagnostic assay based
on the use of peptide nucleic acid (PNA) probes. These molecules
are pseudopeptides that hybridize to complementary nucleic acid
targets (DNA and RNA). In PNA, the counterpart of the sugar
phosphate backbone of DNA and RNA is a polyamide formed by repetitive
units of
N-2-aminoethyl glycine units to which nucleobases are
covalently attached (
3,
17). Previously, PNA fluorescence in
situ hybridization (FISH) tests targeting rRNA have been used
to differentiate and/or identify yeast and bacterium species
(
17-
19).
For this study, trypanosomes, Leishmania donovani, and Plasmodium falciparum AS strain were obtained from the Institute of the Tropical Medicine, Antwerp, Belgium, and the Swiss Tropical Institute, Basel, Switzerland (Table 1). Other species such as Escherichia coli 25922 and Saccharomyces cerevisiae 4098 were obtained from the American Type Cell Collection, Manassas, Va. All analytical samples were fixed at 4°C for 1 h with 1 ml of 1.5% formaldehyde-PBS. After centrifugation at 10,000 x g for 10 s, pellets were resuspended and treated with 50% ethanol (Merck)-MilliQ water solution for a minimum of 1 h at -20°C. Next, 10 µl of sample suspension was applied onto a microscopy slide and dried for 10 min at 60°C. Alternatively, thin blood smears were prepared using 2 µl of human and mouse blood containing various trypanosomes. Next, smears were fixed with methanol (Merck) for 5 min at room temperature and air dried. For cytospin analysis of blood samples, erythrocytes were first lysed with erythrocyte lysing buffer from Qiagen (Westbourgh, The Netherlands). Cell suspensions (200 µl) were centrifuged and spotted onto microscopy slides using a Stlandos/Elliott cytospin. Slides were air dried and fixed with methanol as described above.
In order to identify targets for the design of PNA probes, database-available
Trypanozoon 18S ribosomal DNA sequences were aligned. BLAST
searches did not detect any other protozoan ribosomal DNA sequences
with a 100% identity match to the selected target sequences.
Three 13- to 15-nucleotide-long PNA probesTbr7 (CGGAACCCAGCCA),
Tbr16 (GCCCTAACAGGTGTG), and Tbr18 (GTTGCCACCAGCAGT)were
synthesized. For the analysis of PNA binding, total RNA was
extracted from DE52-purified trypanosomes (
12) or parasite-spiked
blood, using a Qiagen extraction kit, and dot blot hybridization
was performed as described before (
6). Briefly, 20 ng in 10
µl of total RNA was blotted onto nylon membranes (Gibco-BRL),
which were subsequently incubated in hybridization buffer with
400 nM PNA probes for 60 min at 45 or 55°C. Next, membranes
were washed three times for 5 min at 50°C, and development
was carried out as described before (
6).
The PNA FISH itself was performed as previously described (17). Briefly, smears were treated with 20 to 40 µl of 400 nM fluorescein-labeled PNA probe in hybridization buffer and hybridized at 45 or 55°C for 90 min. The excess of PNA probe was removed by immersion of the microscope slides into in prewarmed (45°C) washing buffer for 30 min. The slides were further analyzed using fluorescence microscope (Leica) as described before (17).
In order to validate the fluorescein-labeled PNA probes, they were first tested for their specificity in dot blot hybridization, using RNA of various reference trypanosomes as well as control pathogenic and nonpathogenic microorganisms (Table 1). As shown in Fig. 1, at 45°C, PNA probes Tbr7 and Tbr18 hybridized strongly to RNA of T. brucei gambiense, T. brucei rhodesiense, T. brucei brucei, T. evansi, and T. equiperdum (Trypanozoon subgenus) and a human blood sample spiked with T. brucei rhodesiense. PNA probes Tbr7 and Tbr18 did not hybridize to control RNA sequences of Nannomonas (T. congolense), P. falciparum, L. donovani, E. coli, or S. cerevisiae (Fig. 1). PNA probe Tbr16 gave a strong hybridization signal at 55°C, detecting RNA of all Trypanozoon species, while slightly cross hybridizing to RNA of T. congolense from the subgenus Nannomonas. The same PNA probe did not hybridize to the remaining control RNA sequences (Fig. 1). A universal PNA probe (EU/uni2) targeting many known eukaryotic sequences served as a positive control for the RNA preparations (Fig. 1). Next, PNA probes were tested in slide-based FISH for direct trypanosome identification in smears of purified parasites as well as blood and tissue samples. Concordant with the dot blot results, a clear and strong fluorescence signal was obtained with PNA probes Tbr17 and Tbr18 using 90 min of hybridization at 45°C. Probe Tbr16 strongly hybridized at 55°C. As demonstrated in Fig. 2 A to C using all probes, individual parasites were easily detectable by their bright green fluorescence, localized in the trypanosome cytoplasm. The fluorescent signal was absent in DAPI (4',6'-diamidino-2-phenylindole)-stained organelles such as nucleus and kinetoplast. The negative control PNA probe specific for Staphylococcus aureus did not hybridize to any trypanosome 18S rRNA (Fig. 2D). Similar results were obtained when analyzing thin smears of trypanosome-containing human or mouse blood and spleen or liver cell suspension smears that had been prepared as described earlier (16). Here, a single parasite could be detected in a 2-µl blood smear. This corresponds to 500 trypanosomes/ml of blood, i.e., a detection limit 100 times more sensitive than the conventional counting chamber detection limit. This detection limit was further improved when PNA FISH was combined with a cytospin technique. Using serial dilutions of parasite-blood samples, a single parasite in a 200-µl volume could be detected, thus equaling a detection limit of five parasites/ml.
To date, control of sleeping sickness heavily relies on active
patient diagnosis and correct drug treatment (
21). As conventional
parasite detection by microscopy suffers from limited sensitivity,
we present in this paper a new diagnostic test, the
Trypanozoon-specific
PNA FISH. This test facilitates the microscopic detection of
a single trypanosome cell by targeting widely distributed and
conserved cytoplasmic multicopy 18S rRNA sequences with PNA
probes. Advantages of the PNA probes are as follows. (i) They
are designed by BLAST search to match specifically phylogenetically
highly conserved
Trypanozoon 18S rRNA, avoiding loss of detection
by antigenic variation and avoiding cross-reactivity with other
protozoan parasites. (ii) Their high hybridization performance
saves time over DNA-based hybridization (
1,
2,
14). (iii) Their
resistance to cellular proteases and nucleases makes them less
prone to degradation during hybridization procedures (
3,
17).
(iv) Methanol-fixed smears prepared for
Plasmodium screenings
can be costained for PNA FISH analysis. (v) The use of fluorescence
microscopy makes
Trypanozoon PNA FISH adaptable to the majority
of clinical laboratories.
In the past, various PCR tests have been developed to detect trypanosomes. Although primers were derived from the repetitive DNA sequences, the detection limit obtained with blood samples was only in the range of 40 trypanosomes/ml of blood. This is not significantly different from conventional parasitological laboratory detection techniques such as the mini-anion-exchange column technique (4, 9-11, 15, 20). In comparison, Trypanozoon PNA FISH with undiluted thin blood smears is a much-simplified rapid way of specific parasite detection, still reaching a detection limit of 500 trypanosomes/ml of blood. By adding a cytospin step, this limit can be improved to five parasites/ml, equaling an optimal PCR detection limit on blood samples. To prove the test's field reliability in detection of sleeping sickness in the different infection foci known today, future on-site studies will be needed. However, based on the blood-spiked tests provided here, PNA FISH looks to be a promising new tool in the fight against sleeping sickness.

ACKNOWLEDGMENTS
We are particularly grateful to Eddy Magnus, Luc Verhelst, Rudi
Baelmans, and Peter Ilegems for their technical assistance.
S.M. is supported by a postdoctoral fellowship of the Foundation for Scientific Research-Flanders.

FOOTNOTES
* Corresponding author. Present address: Department of Immunology, Groote Schuur Hospital, Old Main Building H47, Observatory 7925, Cape Town, South Africa. Phone: 27 21 404 4013. Fax: 27 21 448 6116. E-mail:
mradwans{at}uctgsh1.uct.ac.za.


REFERENCES
1 - Bromidge, T., W. Gibson, K. Hudson, and P. Dukes. 1993. Identification of Trypanosoma brucei gambiense by PCR amplification of variant surface glycoprotein genes. Acta Trop. 53:107-119.[Medline]
2 - Dukes, P., W. C. Gibson, J. K. Gashumba, K. M. Hudson, and T. J. Bromidge, A. Kaukus, T. Asonganyi, and E. Magnus. 1992. Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon. Acta Trop. 51:123-134.[Medline]
3 - Egholm, M., O. Buchard, L. Christensen, C. Behrens, S. M. Freirer, D. A. Driver, R. H. Berg, S. K. Kim, B. Norden, and P. E. Nielsen. 1993. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen bonding rules. Nature 365:556-568.
4 - Enyaru, J. C. K., E. Matovu, M. Akol, C. Sebikali, J. Kyambadde, C. Schmid, R. Brun, R. Kaminsky, L. M. Ogwal, and F. Kansiime. 1998. Parasitological detection of Trypanosoma brucei gambiense in serologically negative sleeping sickness suspects from North-west Uganda. Ann. Trop. Med. Parasitol. 92:845-850.[Medline]
5 - Gibson, W. 1986. Will the real Trypanosoma brucei gambiense please stand up? Parasitol. Today 2:255-257.[CrossRef][Medline]
6 - Gildea, B. D., C. Shelagh, J. MacNeill, H. Perry-O Keefe, D. Sorensen, and J. M. Coull. 1998. PNA solubility enhancers. Tetrahedron Lett. 39:7255-7258.[CrossRef]
7 - Hide, G. 1999. History of sleeping sickness. Clin. Microbiol. Rev. 12:112-125.[Abstract/Free Full Text]
8 - Hoare, C. A. 1972. The trypanosomes of mammals. Blackwell Scientific Publication, Oxford, United Kingdom.
9 - Kabiri, M., J. R. Franco, P. P. Simarro, J. A. Ruiz, M. Sarsa, and D. Steverding. 1999. Detection of Trypanosoma brucei gambiense in sleeping sickness suspects by PCR amplification of expression-site-associated genes 6 and 7. Trop. Med. Int. Health 4:658-661.[CrossRef][Medline]
10 - Kanmogne, G. D., T. Asonganyi, and W. C. Gibson. 1996. Detection of Trypanosoma brucei gambiense, in serologically positive but aparasitaemic sleeping sickness suspects in Cameroon, by PCR. Ann. Trop. Med. Parasitol. 90:475-483.[Medline]
11 - Kyambadde, J. W., J. C. K. Enyaru, E. Matovu, M. Odiit, and J. F. Carasco. 2000. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bull. W. H. O. 78:119-124.[Medline]
12 - Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28:521-534.[CrossRef][Medline]
13 - Magnus, E., T. Vervoort, and N. Van Miervenne. 1978. A card agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belg. Med. Trop. 58:169-176.[Medline]
14 - Pays, E., L. Vanhamme, and M. Berberof. 1994. Genetic controls for the expression of surface proteins in African trypanosomes. Annu. Rev. Microbiol. 48:25-52.[Medline]
15 - Penchenier, L., G. Simo, P. Grebaut, S. Nkinin, C. Laveissiere, and S. Herder. 2000. Diagnosis of human trypanosomiasis, due to Trypanosoma brucei gambiense in central Africa, by the polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 94:392-394.[Medline]
16 - Radwanska, M., S. Magez, A. Michel, B. Stijlemans, M. Geuskens, and E. Pays. 2000. Comparative analysis of antibody responses against HSP, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei. Infect. Immun. 68:848-860.[Abstract/Free Full Text]
17 - Stender, H., K. Lund, K. H. Petersen, O. F. Rasmussen, P. Hongmanee, H. Miorner, and S. E. Godtfredsen. 1999. Fluorescence in situ hybridization assay using peptide nucleic acid probes for differentiation between tuberculous and nontuberculous species in smears of Mycobacterium cultures. J. Clin. Microbiol. 37:2760-2765.[Abstract/Free Full Text]
18 - Stender, H., C. Kurtzman, J. J. Hyldig-Nielsen, D. Sorensen, D., A. Broomer, K. Oliveira, H. Perry O'Keefe, A. Sage, B. Young, and J. Coull. 2001. Identification of Dekkera bruxellensis (Brettanomyces) from wine by fluorescence in situ hybridization using peptide nucleic acid probes. Appl. Environ. Microbiol. 67:938-941.[Abstract/Free Full Text]
19 - Stender, H., K. Oliveira, S. Rigby, F. Bargoot, and J. Coull. 2001. Rapid detection, identification, and enumeration of Escherichia coli by fluorescence in situ hybridization using an array scanner. J. Microbiol. Methods 45:31-39.[CrossRef][Medline]
20 - Truc, P., V. Jamonneau, G. Cuny, G., and J. L. Frezil. 1999. Use of polymerase chain reaction in human African trypanosomosis stage determination and follow-up. Bull. W. H. O. 77:745-748.[Medline]
21 - Van Meirvenne, N. 1999. Biological diagnosis of human African trypanosomiasis, p. 235-252. In M. Dumas, B. Bouteille, and A. Buguet (ed.), Progress in human trypanosomiasis, sleeping sickness. Springer, Paris, France.
Journal of Clinical Microbiology, November 2002, p. 4295-4297, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.4295-4297.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Stijlemans, B., Conrath, K., Cortez-Retamozo, V., Van Xong, H., Wyns, L., Senter, P., Revets, H., De Baetselier, P., Muyldermans, S., Magez, S.
(2004). Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies: AFRICAN TRYPANOSOMES AS PARADIGM. J. Biol. Chem.
279: 1256-1261
[Abstract]
[Full Text]